Thomas Aparicio

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Venues

British journal of cancer

Cancers

International journal of cancer

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Jean-Louis Legoux, Roger Faroux, Nicolas Barrière, Karine Le Malicot, David Tougeron, Véronique Lorgis, Véronique Guerin-Meyer, Vincent Bourgeois, David Malka, Thomas Aparicio, Matthieu Baconnier, Valérie Lebrun-Ly, Joëlle Egreteau, Faïza Khemissa Akouz, Magali Terme, Côme Lepage, Valérie Boige
First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA). Cancers 16 (8) (2024)
Thomas Aparicio, Anna Carteaux-Taieb, Amélie Arégui, Janina Estrada, Geoffroy Beraud-Chaulet, Virginie Fossey-Diaz, Pascal Hammel, Pierre Cattan
Management of esogastric cancer in older patients. Therapeutic advances in medical oncology 16 (2024)
Thomas Aparicio, Julie Henriques, Magali Svrcek, Aziz Zaanan, Sylvain Manfredi, Stefano Cascinu, David Tougeron, Jean-Marc Gornet, Marine Jary, Eric Terrebonne, Guillaume Piessen, Pauline Afchain, Cédric Lecaille, Marc Pocard, Thierry Lecomte, Margherita Rimini, Frédéric Di Fiore, Valérie Le Brun Ly, Stefano Cascinu, Dewi Vernerey, Pierre Laurent-Puig
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases. British journal of cancer (2024)
Thomas Aparicio, Julie Henriques, Magali Svrcek, Aziz Zaanan, Sylvain Manfredi, Stefano Cascinu, David Tougeron, Jean-Marc Gornet, Marine Jary, Eric Terrebonne, Guillaume Piessen, Pauline Afchain, Cédric Lecaille, Marc Pocard, Thierry Lecomte, Margherita Rimini, Frédéric Di Fiore, Valérie Le Brun Ly, Stefano Cascinu, Dewi Vernerey, Pierre Laurent-Puig
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases. British journal of cancer 131 (1) (2024)
Thomas Aparicio, Julie Henriques, Magali Svrcek, Aziz Zaanan, Sylvain Manfredi, Stefano Cascinu, David Tougeron, Jean-Marc Gornet, Marine Jary, Eric Terrebonne, Guillaume Piessen, Pauline Afchain, Cédric Lecaille, Marc Pocard, Thierry Lecomte, Margherita Rimini, Frédéric Di Fiore, Valérie Le Brun Ly, Stefano Cascinu, Dewi Vernerey, Pierre Laurent-Puig
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases. British journal of cancer 131 (1) (2024)
Thomas Aparicio, Julie Henriques, Magali Svrcek, Aziz Zaanan, Sylvain Manfredi, Stefano Cascinu, David Tougeron, Jean-Marc Gornet, Marine Jary, Eric Terrebonne, Guillaume Piessen, Pauline Afchain, Cédric Lecaille, Marc Pocard, Thierry Lecomte, Margherita Rimini, Frédéric Di Fiore, Valérie Le Brun Ly, Stefano Cascinu, Dewi Vernerey, Pierre Laurent-Puig
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases. British journal of cancer 131 (1) (2024)
Jean-Louis Legoux, Roger Faroux, Nicolas Barrière, Karine Le Malicot, David Tougeron, Véronique Lorgis, Véronique Guerin-Meyer, Vincent Bourgeois, David Malka, Thomas Aparicio, Matthieu Baconnier, Valérie Lebrun-Ly, Joëlle Egreteau, Faïza Khemissa Akouz, Magali Terme, Côme Lepage, Valérie Boige
First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA). Cancers 16 (8) (2024)
Thomas Aparicio, Julie Henriques, Magali Svrcek, Aziz Zaanan, Sylvain Manfredi, Stefano Cascinu, David Tougeron, Jean-Marc Gornet, Marine Jary, Eric Terrebonne, Guillaume Piessen, Pauline Afchain, Cédric Lecaille, Marc Pocard, Thierry Lecomte, Margherita Rimini, Frédéric Di Fiore, Valérie Le Brun Ly, Stefano Cascinu, Dewi Vernerey, Pierre Laurent-Puig
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases. British journal of cancer 131 (1) (2024)
Elodie Martin, Karine Le Malicot, Catherine Guerin-Charbonnel, François Bocquet, Olivier Bouche, Anthony Turpin, Thomas Aparicio, Jean-Louis Legoux, Laetitia Dahan, Julien Taieb, Côme Lepage, Louis-Marie Dourthe, Caroline Pétorin, Vincent Bourgeois, Jean-Luc Raoul, Valérie Seegers
How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology. Current oncology (Toronto, Ont.) 31 (6) (2024)
Elodie Martin, Karine Le Malicot, Catherine Guerin-Charbonnel, François Bocquet, Olivier Bouche, Anthony Turpin, Thomas Aparicio, Jean-Louis Legoux, Laetitia Dahan, Julien Taieb, Côme Lepage, Louis-Marie Dourthe, Caroline Pétorin, Vincent Bourgeois, Jean-Luc Raoul, Valérie Seegers
How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology. Current oncology (Toronto, Ont.) 31 (6) (2024)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Pauline Marolleau, David Tougeron, Benoit Allignet, Romain Cohen, David Sefrioui, Blandine Gallet, Frédéric Dumont, Rosine Guimbaud, Emily Alouani, Guillaume Passot, Grégoire Desolneux, François Ghiringhelli, Frédéric Marchal, Farouk Mourthadhoi, Romain Coriat, Romain Desgrippes, Christophe Locher, Gaël Goujon, Gaëtan Des Guetz, Thomas Aparicio, Etienne Paubelle, Aurélien Dupré, Christelle De La Fouchardière
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study. International journal of cancer (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Julie Bonnereau, Tristan Courau, Nicolas Asesio, Delphine Salfati, Fatiha Bouhidel, Hélène Corte, Sarah Hamoudi, Nassim Hammoudi, Julie Lavolé, Justine Vivier-Chicoteau, Victor Chardiny, Leon Maggiori, Mathieu Blery, Romain Remark, Cécile Bonnafous, Pierre Cattan, Antoine Toubert, Purnima Bhat, Matthieu Allez, Thomas Aparicio, Lionel Le Bourhis
Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition. Gut (2022)
Thomas Aparicio, Atanas Pachev, Pierre Laurent-Puig, Magali Svrcek
Epidemiology, Risk Factors and Diagnosis of Small Bowel Adenocarcinoma. Cancers 14 (9) (2022)
Catherine Conti, Frederic Pamoukdjian, Thomas Aparicio, Soraya Mebarki, Johanne Poisson, Gilles Manceau, Julien Taieb, Bastien Rance, Sandrine Katsahian, Anaïs Charles-Nelson, Elena Paillaud
Overall Survival and Prognostic Factors among Older Patients with Metastatic Pancreatic Cancer: A Retrospective Analysis Using a Hospital Database. Cancers 14 (5) (2022)
Camille Evrard, Stéphane Messina, David Sefrioui, Éric Frouin, Marie-Luce Auriault, Romain Chautard, Aziz Zaanan, Marion Jaffrelot, Christelle De La Fouchardière, Thomas Aparicio, Romain Coriat, Julie Godet, Christine Silvain, Violaine Randrian, Jean-Christophe Sabourin, Rosine Guimbaud, Elodie Miquelestorena-Standley, Thierry Lecomte, Valérie Moulin, Lucie Karayan-Tapon, Gaëlle Tachon, David Tougeron
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers. International journal of molecular sciences 23 (8) (2022)
Camille Evrard, Thomas Aparicio, Emilie Soularue, Karine Le Malicot, Jérôme Desramé, Damien Botsen, Farid El Hajbi, Daniel Gonzalez, Come Lepage, Olivier Bouche, David Tougeron, null On Behalf Of The Durigast-Prodige Investigators/Collaborators
Safety of FOLFIRI + Durvalumab +/- Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59. Biomedicines 10 (5) (2022)
Marc Ychou, Michel Rivoire, Simon Thezenas, Rosine Guimbaud, François Ghiringhelli, Anne Mercier-Blas, Laurent Mineur, Eric Francois, Faiza Khemissa, Marion Chauvenet, Reza Kianmanesh, Marianne Fonck, Philippe Houyau, Thomas Aparicio, Marie-Pierre Galais, Franck Audemar, Eric Assenat, Evelyne Lopez-Crapez, Claire Jouffroy, Antoine Adenis, René Adam, Olivier Bouché
Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial. British journal of cancer 126 (9) (2022)
Thomas Aparicio, Magali Svrcek, Julie Henriques, Pauline Afchain, Astrid Lièvre, David Tougeron, Johan Gagniere, Eric Terrebonne, Guillaume Piessen, Jean-Louis Legoux, Cédric Lecaille, Marc Pocard, Jean-Marc Gornet, Aziz Zaanan, Sandrine Lavau-Denes, Thierry Lecomte, David Deutsch, Dewi Vernerey, Pierre Laurent Puig
Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort. International journal of cancer 148 (7) (2021)
Philippe Wind, Zoe Ap Thomas, Marie Laurent, Thomas Aparicio, Matthieu Siebert, Etienne Audureau, Elena Paillaud, Guilhem Bousquet, Frédéric Pamoukdjian
The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery. Cancers 14 (1) (2021)
Nicolas Giraud, Olivier Saut, Thomas Aparicio, Philippe Ronchin, Louis-Arnaud Bazire, Emilie Barbier, Claire Lemanski, Xavier Mirabel, Pierre-Luc Etienne, Astrid Lièvre, Wulfran Cacheux, Ariane Darut-Jouve, Christelle De La Fouchardière, Arnaud Hocquelet, Hervé Trillaud, Thomas Charleux, Gilles Breysacher, Delphine Argo-Leignel, Alexandre Tessier, Nicolas Magné, Meher Ben Abdelghani, Côme Lepage, Véronique Vendrely
MRI-Based Radiomics Input for Prediction of 2-Year Disease Recurrence in Anal Squamous Cell Carcinoma. Cancers 13 (2) (2021)
Thomas Aparicio, Nathalie Cozic, Christelle de la Fouchardière, Emeline Meriaux, Jérome Plaza, Laurent Mineur, Rosine Guimbaud, Emmanuelle Samalin, Florence Mary, Thierry Lecomte, Carlos Gomez-Roca, Paul-Arthur Haineaux, Alain Gratet, Jannick Selves, Yves Menu, Nikias Colignon, Laetitia Johnson, Frédéric Legrand, Gilles Vassal
The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program. Targeted oncology 16 (3) (2021)
Julie Niogret, Emeric Limagne, Marion Thibaudin, Julie Blanc, Aurelie Bertaut, Karine Le Malicot, Yves Rinaldi, François-Xavier Caroli-Bosc, Franck Audemar, Suzanne Nguyen, Corinne Sarda, Catherine Lombard-Bohas, Christophe Locher, Miguel Carreiro, Jean-Louis Legoux, Pierre-Luc Etienne, Mathieu Baconnier, Marc Porneuf, Thomas Aparicio, François Ghiringhelli
Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma. Cancers 12 (6) (2020)
Edouard Auclin, Julien Taieb, Come Lepage, Thomas Aparicio, Roger Faroux, Enrico Mini, Gunnar Folprecht, Ramon Salazar, Magdalena Benetkiewicz, Maria Banzi, Christophe Louvet, Jean-Luc Van Laethem, Josep Tabernero, Tamas Hickish, Aimery de Gramont, Thierry André, Dewi Vernerey
Carcinoembryonic Antigen Levels and Survival in Stage III Colon Cancer: Post hoc Analysis of the MOSAIC and PETACC-8 Trials. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 28 (7) (2020)
Thomas Aparicio, Julie Henriques, Sylvain Manfredi, David Tougeron, Olivier Bouché, Denis Pezet, Guillaume Piessen, Romain Coriat, Aziz Zaanan, Jean-Louis Legoux, Eric Terrebone, Marc Pocard, Jean-Marc Gornet, Thierry Lecomte, Catherine Lombard-Bohas, Hervé Perrier, Cédric Lecaille, Sandrine Lavau-Denes, Dewi Vernerey, Pauline Afchain, null null
Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients. International journal of cancer 147 (4) (2020)
David Tougeron, Benjamin Sueur, Aziz Zaanan, Christelle de la Fouchardiére, David Sefrioui, Thierry Lecomte, Thomas Aparicio, Gaetan Des Guetz, Pascal Artru, Vincent Hautefeuille, Romain Coriat, Valerie Moulin, Christophe Locher, Yann Touchefeu, Cedric Lecaille, Gael Goujon, Aurélie Ferru, Camille Evrard, Romain Chautard, Lucie Gentilhomme, Dewi Vernerey, Julien Taieb, Thierry André, Julie Henriques, Romain Cohen, null null
Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study. International journal of cancer 147 (1) (2020)
Anthony Dohan, Benoit Gallix, Boris Guiu, Karine Le Malicot, Caroline Reinhold, Philippe Soyer, Jaafar Bennouna, Francois Ghiringhelli, Emilie Barbier, Valérie Boige, Julien Taieb, Olivier Bouché, Eric François, Jean-Marc Phelip, Christian Borel, Roger Faroux, Jean-Francois Seitz, Stéphane Jacquot, Meher Ben Abdelghani, Faiza Khemissa-Akouz, Dominique Genet, Jean Louis Jouve, Yves Rinaldi, Françoise Desseigne, Patrick Texereau, Etienne Suc, Come Lepage, Thomas Aparicio, Christine Hoeffel, null null
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab. Gut 69 (3) (2019)

Thomas Aparicio.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Aparicio